Delivery Order SPE2DB24D2100-SPE2DB25FBCPA

Award Date 3/4/25
Potential Completion Date 3/25/25
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEKLURY (remdesivir) 100 mg vials. The contract, valued at $15,848.80, is a firm fixed-price delivery order that runs through March 11, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of Veklury (Remdesivir) 100 mg vials, a treatment for COVID-19. The contract has a ceiling value of $6,809.20 and runs through July 31, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,042.76 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a key therapeutic used to treat COVID-19. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This is a $13,618.40 delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The firm-fixed-price contract runs through July 25, 2024 and was awarded on a full and open competition basis without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEKLURY (Remdesivir) 100 mg vials. The delivery order is valued at $13,618.40 and has a completion date of April 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Veklury (Remdesivir) 100 mg vials. The contract has a total ceiling value of $17,023.00 and a period of performance through January 29, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The contract is a firm fixed-price Delivery Order with a ceiling value of $4,754.64 and an ultimate completion date of February 13, 2025. The contract is not set aside for any specific business category....
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The $13,606.80 firm-fixed-price contract has an ultimate completion date of March 1, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The award, valued at $13,618.40, is for the delivery of 100 mg vials of the antiviral drug Veklury (remdesivir). This is a firm-fixed-price delivery order contract with an ultimate completion date of August 21, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $13,618.40 contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a COVID-19 treatment medication. The contract has a completion date of February 9, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBCPA
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The total ceiling value of the contract is $3,169.76, with a period of performance through March 25, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 6/3/25, 9:57 AM